• NEWS

The COVID pandemic’s lingering impact on clinical trials

Medical researchers are beginning to shift their focus away from COVID-19 — but the pandemic could continue to affect studies focused on other diseases.
By
  1. Heidi Ledford
    View author publications

    You can also search for this author in PubMed  Google Scholar

Access through your institution
Buy or subscribe

“It’s like time stopped,” says Emilia Bagiella, a clinical trial statistician at the Icahn School of Medicine at Mount Sinai in New York City.

Access options

Access through your institution

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Nature 595, 341-342 (2021)

doi: https://doi.org/10.1038/d41586-021-01569-9

References

  1. Unger, J. M. & Xiao, H. Trials 22, 260 (2021).

    Article  PubMed  Google Scholar 

  2. Fleury, M. E., Farner, A. M. & Unger, J. M. JAMA Oncol. 7, 131–132 (2021).

    Article  Google Scholar 

Download references

Subjects

Latest on:

Nature Careers

Jobs

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing